CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Gastrointestinal Cancers » Colorectal Cancer

 

3D endosonography improves anal cancer staging

C. P. Kaiser
March 7, 2003

Accurate treatment planning for anal carcinomas helps to avoid recurrence. Three-D endosonography, compared with 2D, improves the detection of lymph nodes and of tumor spread, according to Danish researchers.

Dr. Anders F. Christensen and colleagues from Copenhagen examined 30 patients with a 10 MHz rotating endoprobe. Cross-sectional images (2D) of the anal sphincters were stored on a 3D system during retraction of the endoprobe through the anal canal. Afterwards, any projection (e.g., coronal and sagittal) could be reconstructed.

The 2D and 3D images were compared according to five parameters concerning tumor spread:
? invasion into the internal anal sphincter
? invasion into the external anal sphincter
? penetration beyond the external anal sphincter
? location of outer tumor limits
? detection of lymph nodes (the number was noted as well)

"Ideally, these five parameters should be identical in 2D and 3D endosonography," Christensen said.

The 3D method detected a median of five definitive findings, compared with a median of four findings by the 2D method, a significant result, Christensen said.

In eight patients, only 3D endosonography visualized the border of tumor spread. The median number of lymph nodes visualized in 3D was one, in 2D it was zero, another significant finding. In certain patients, 2D endosonography saw no lymph nodes, while 3D reconstruction picked them up.

He concluded that 3D allows accurate measurement of tumor size in any projection, while 2D allows assessment only in the scanning plane.

In another study, Dr. Christiane Kulinna from Vienna, Austria, and colleagues from Munich, Germany, found sagittal and coronal multiplanar reconstructions (MPR) of MDCT superior to standard axial reconstructions in local staging of rectal cancer. The reconstruction takes only an additional five minutes.

Fifty-five patients with histologic proven rectal cancer underwent MDCT of the abdomen. The raw data were acquired with a collimation of 1 mm, a pitch of 6, and an imaging reconstruction with 0.6 mm increment.

MPR in sagittal and coronal planes (5 mm slice thickness, 4 mm increment) were calculated from the raw data and compared to 5 mm axial reconstructions. Two blinded observers evaluated the local T- and N-staging first in axial, then in axial, sagittal, and coronal views within one week. Researchers did not differentiate T1 and T2 tumors.

Interobserver correlation was good, according to Kulinna.

For precise lymph node staging, 12 lymph nodes and five lymph nodes after radiochemotherapy had to be examined histopathologically.

Axial CT slices combined with MPR images showed accuracy rates of 76% for preoperative T-staging and 92% for detection of lymph node metastases. In up to 18% of the cases, MPR, especially sagittal slices, was more informative than axial images about the extent of the tumor invasion, Kulinna said.

In response to an audience member's questions, Kulinna said that based on results from another study, MR is better than CT at looking at the mesorectal fascia. A separate study determined there was no difference in results using 1, 3, and 5 mm slice thickness.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

Axitinib Fails to Improve Survival in Metastatic Colorectal Cancer
May 6, 2013
A 47-Year-Old Patient With Chronic Abdominal Pain
April 26, 2013
Endometrial Cancer at Young Age Ups Risk for Colorectal Cancer
April 22, 2013
Smoking Linked to Poorer Prognosis in Colon Cancer
April 13, 2013
Colorectal Lesions
March 8, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
Click here to subscribe to our newsletter


 
SEARCH MEDICA SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Colorectal Cancer
Evidence on Colorectal Cancer
Guidelines on Colorectal Cancer
Patient Education on Colorectal Cancer
Clinical Trials on Colorectal Cancer
Practical Articles on Colorectal Cancer
Research and Reviews on Colorectal Cancer
All "Colorectal Cancer" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy